Stereotactic Radiosurgery (SRS) for Spine Metastases

Stopped early · Not applicable

Conditions studied: Spinal Metastases

In brief

This study will evaluate the most effective radiation dose. Patients will be randomized (like flipping a coin) to receive either low dose stereotactic radiotherapy (defined as "14 Gy") or high dose stereotactic radiotherapy (defined as 18 Gy).

Key facts

Study ID
NCT00593320
Run by
Washington University School of Medicine
People needed
2
Starts
2007-09-01
Expected to finish
2010-03-01
Last updated by the study team
2015-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.